The Biomedical Discovery and Commercialization (BDC) program is a limited enrollment offering by the Department of Biochemistry and Biomedical Sciences with key contributions from the DeGroote School of Business. The training program encompasses level III and IV of undergraduate studies as well as a 12-month course-based Master’s program. The latter includes a 4 to 8 month internship in the health sciences sector. This limited enrollment program will afford a unique educational experience for students seeking first-rate training in the biomedical sciences with an emphasis on drug discovery and development. |
Test Scores: | - International English Language Testing System (academic or immigration) [min. 6.5] or Canadian Academic English Language Assessment [min. 70] or Test of English as a Foreign Language (Internet Based) [min. 86] or Cambridge English for Speakers of Other Languages: Certificate in Advanced English [min. 190] or DuoLingo [min. 115]
|
Application Notes : | Students who have been asked to meet McMaster’s English Language Proficiency requirement must demonstrate English language proficiency by achieving the minimum requirements as specified by McMaster: IELTS: 6.5, CAE: 190, PTE: 60, CAEL: 70, TOEFL (iBT): 86, DUO: 115. |
Additional Admission Requirements: | Please see website for details. |
* We make every attempt to provide accurate information on prerequisites, programs, and tuition. However, this information is subject to change without notice and we highly recommend that you contact the school to confirm important information before applying.